What is the recommended treatment regimen for post‑herpetic neuralgia?

Treatment of Post-Herpetic Neuralgia

Start with either a tricyclic antidepressant (nortriptyline or desipramine), gabapentin/pregabalin, or topical lidocaine 5% patch as first-line therapy, with the choice depending on whether the pain is localized (use lidocaine patch) versus diffuse (use systemic agents). 1

First-Line Medication Options

Tricyclic Antidepressants (TCAs)

• Begin with nortriptyline or desipramine (secondary amines preferred over tertiary amines like amitriptyline due to fewer anticholinergic side effects) 1
• Start at low doses at bedtime and titrate slowly over 6-8 weeks, including 2 weeks at the highest tolerated dose 1
• Maximum recommended dose is <100 mg/day when possible 1
• Obtain screening ECG in patients >40 years old before initiating therapy 1
• Use with caution in patients with ischemic cardiac disease or ventricular conduction abnormalities 1
• Common adverse effects include dry mouth, orthostatic hypotension, constipation, and urinary retention 1

Calcium Channel α2-δ Ligands

Gabapentin:

• Start at low doses and titrate up to 3600 mg/day in 3 divided doses as tolerated 1
• An adequate trial requires 2 months or more 1
• Most extensively studied agent for post-herpetic neuralgia 2

Pregabalin:

• Start at 150 mg/day in 2-3 divided doses 1
• Titrate to 300 mg/day after 1-2 weeks 1
• Can increase to 600 mg/day if inadequate relief at 300 mg/day, though higher doses show more adverse effects without consistently greater efficacy 1
• Provides faster pain relief than gabapentin due to linear pharmacokinetics and more straightforward dosing 1

Topical Lidocaine 5% Patch

• Use specifically for well-localized peripheral post-herpetic neuralgia with allodynia 1
• Apply up to 3 patches for maximum of 12-18 hours daily 1
• Excellent tolerability with only mild local reactions; no significant systemic absorption 1
• Particularly advantageous in elderly patients due to lack of systemic adverse effects and drug interactions 1
• Unlikely to benefit patients with central neuropathic pain 1
• 5% lidocaine gel is a less expensive alternative that has also shown efficacy 1

Second-Line Options (First-Line in Specific Circumstances)

Opioids and Tramadol

• Reserve for patients who fail first-line medications, OR use as first-line for acute severe pain, cancer-related pain, or episodic severe exacerbations 1
• Tramadol: Start 50 mg once or twice daily, increase by 50-100 mg/day every 3-7 days as tolerated, maximum 400 mg/day (300 mg/day in patients >75 years) 1
• Tramadol has lower abuse potential than strong opioids but lowers seizure threshold and can cause serotonin syndrome when combined with SSRIs/SNRIs 1
• Strong opioids (morphine, oxycodone): Start 10-15 mg morphine equivalent every 4 hours, no maximum with careful titration 1

SNRIs (Duloxetine, Venlafaxine)

• Alternative first-line agents with both norepinephrine and serotonin reuptake inhibition 1
• Better tolerated than TCAs in many patients 1

Algorithmic Treatment Approach

Step 1: Establish diagnosis and assess for comorbidities (cardiac disease, renal/hepatic impairment, depression, gait instability) that affect medication selection 1

Step 2: Initiate one first-line medication:

• If localized pain: Topical lidocaine 5% patch alone or combined with systemic agent 1
• If diffuse pain: TCA (nortriptyline/desipramine) OR gabapentin/pregabalin 1
• If acute severe pain or need for rapid relief: Add tramadol or opioid during titration of first-line agent 1

Step 3: Reassess after adequate trial (2-8 weeks depending on agent):

• If pain ≤3/10 with tolerable side effects: Continue current regimen 1
• If pain ≥4/10 (partial relief): Add a second first-line medication from different class 1
• If <30% pain reduction: Switch to alternative first-line medication 1

Step 4: If first-line monotherapy and combination therapy fail, consider referral to pain specialist for interventional treatments (epidural blocks, pulsed radiofrequency of dorsal root ganglion) 3

Critical Pitfalls to Avoid

• Do not delay treatment—earlier initiation improves outcomes 4
• Do not use topical lidocaine for diffuse or central neuropathic pain—it only works for localized peripheral pain 1
• Do not skip ECG screening in patients >40 years before starting TCAs—cardiac toxicity is a real concern 1
• Do not combine tramadol with SSRIs/SNRIs without awareness of serotonin syndrome risk 1
• Do not expect immediate results—adequate trials require 4-8 weeks depending on medication 1

Combination Therapy

Combination therapy is superior to monotherapy when single agents provide inadequate relief 2. The combination of local anesthesia (lidocaine patch) with gabapentin shows particularly good compatibility 2.